Azure Biotech is a private, newly formed biotechnology company that has acquired rights for the development of a novel formulation of lasofoxifene targeting an underserved market in women's health from Ligand Pharmaceuticals. The Azure team is uniquely qualified to bring lasofoxifene forward for targeted new indications and formulations. 

Biotechnology

Azure Biotech

Azure Biotech's headquarters in New York, NY, United States

Nicholas Shubin

Steven R. Goldstein

Lisa Rarick

James A. Simon

Valerie Ceva

Lila Nachtigall

Risa Kagan

Ginger D. Constantine

Susan L. Levinson

Chris Cimarusti

The Advisors and Board Members at Azure Biotech provide strategic guidance and governance, leveraging their extensive expertise to steer the company towards successful development and commercialization of lasofoxifene for new indications in women's health. They engage in high-level decision-making, support critical business initiatives, and ensure compliance with industry standards and regulatory requirements.

Advisors and Board Members

The Leadership Team at Azure Biotech is responsible for guiding the strategic direction and vision of the company, leveraging their extensive expertise in biotechnology and women's health. They oversee the development and commercialization of lasofoxifene, ensuring that innovative solutions are brought to market effectively while fostering collaboration with stakeholders and maintaining strong governance. Their leadership focuses on navigating regulatory pathways and identifying growth opportunities to impact underserved markets positively.

Azure Biotech

Org chart

Board & advisors

Teams

Advisors and Board Members

Leadership Team

Offices

Azure Biotech

Org chart

Board & advisors

Teams

Advisors and Board Members

Leadership Team

Offices

Related companies